Keating Financial Advisory Services’s Amicus Therapeutics FOLD Stock Holding History

Keating Financial Advisory Services’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27	Closed	-$390	–	2649
2026 Q1	$390	Buy	+27	New	+$387	﹤0.01%	2303

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Keating Financial Advisory Services's FOLD Position: Q2 2026 in Review

Keating Financial Advisory Services sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 27 shares — an estimated $390 sold.

Keating Financial Advisory Services first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $390 in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Keating Financial Advisory Services reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Keating Financial Advisory Services sold 27 Amicus Therapeutics shares in Q2 2026, an estimated $390.
Keating Financial Advisory Services first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
Keating Financial Advisory Services's Amicus Therapeutics position peaked at $390 in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.